Fluence and AGL sign deal to deliver the 500 MW / 2000 MWh Tomago Battery Energy Storage System in Australia 31-07-2025, 06:30

Io Therapeutics, Inc., presented today results from studies of IRX4204, the company’s phase II clinical development stage, highly selective RXR nuclear receptor agonist compound, supporting its potential use for treatment of amyotrophic lateral sclerosis 16-07-2024, 20:26

Titan Machinery Inc. Announces Results for Fiscal Fourth 16-03-2023, 17:50